Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do CD2 and CD3-TCR T-cell activation pathways function independently?

D Kabelitz1

  • 1Institut für Immunologie, Universität Heidelberg, FRG.

Immunology Today
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity.

Scandinavian journal of immunology·2017
Same author

CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.

Scandinavian journal of immunology·2017
Same author

Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides.

Zeitschrift fur Rheumatologie·2016
Same author

[Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides. German version].

Zeitschrift fur Rheumatologie·2016
Same author

Lysosome-Related Effector Vesicles in T Lymphocytes and NK Cells.

Scandinavian journal of immunology·2015
Same author

Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4⁺ T cells in granulomatosis with polyangiitis.

Clinical and experimental rheumatology·2015
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

T cells activate via CD3-T-cell receptor (TCR) or CD2 pathways. Discovering CD2-negative T cells offers new insights into the relationship between these T-cell activation mechanisms.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • T cells are crucial immune cells with distinct activation pathways.
  • The CD3-T-cell receptor (TCR) complex and CD2 molecule are known mediators of T-cell activation.
  • Previous research suggests a potential link between CD3-TCR and CD2-mediated T-cell activation.

Purpose of the Study:

  • To explore recent advancements in understanding T-cell activation mechanisms.
  • To investigate the role of CD2 in T-cell activation, particularly in the context of CD2-negative T cells.
  • To examine the interrelationship between CD3-TCR and CD2 T-cell activation pathways.

Main Methods:

  • Review of recent scientific literature on T-cell activation.
  • Analysis of findings related to T-cell surface markers, specifically CD2 expression.

Related Experiment Videos

  • Comparative study of T-cell activation through CD3-TCR and CD2 pathways.

    • Main Results:

    • Recent findings indicate the existence of T cells that do not express CD2.
    • The identification of CD2-negative T cells challenges previous assumptions about universal CD2 involvement in T-cell activation.
    • This discovery provides a new avenue for dissecting the distinct and potentially interconnected roles of CD3-TCR and CD2.

    Conclusions:

    • The existence of CD2-negative T cells necessitates a refined understanding of T-cell activation.
    • Further research is warranted to elucidate the functional consequences of CD2-negative T cells.
    • This finding opens novel approaches to study the interplay between CD3-TCR and CD2-mediated T-cell activation.